Anal Cancer Series #5: Michael Anderson - Lived Experience of Anal Cancer

Trigger Warning: this episode talks about cancer, HPV, anal cancer, cancer treatment, side effects, sec and intimacy, clinical trials and stigma.Supported by an unrestricted grant from Incyte Biosciences. Incyte had no involvement in the development, content, or editorial review of the activities associated with this initiative.Description:In this educational episode, Naman Julka-Anderson and Jo McNamara sit down with Michael Anderson. This episode is a deep dive into Michael’s diagnosis, treatment, side effects, clinical trials and Bottomline charity he founded.Michael worked in policy and research for many years and was was diagnosed with anal cancer in 2020. He set up the Bottom Line support group for people living with anal cancer in 2021 which became a charity in 2024. He worked as a patient expert on the National Cancer Plan in 2025 and speaks regularly at conferences, seminars and training events. CPD Reflection Points:Consider how this episode has influenced your understanding of the role that sexual orientation and identity can play in a patient’s cancer journey, and how might this shape the way you deliver more inclusive, person-centred care in the future?Reflect on your confidence in discussing sex and intimacy with men who have sex with men.What insights have you gained on the importance of support networks  and how could you incorporate signposting to such services into your clinical practice?Complete this form for your accredited digital badge: Digital Badge Form.Links from the Episode:Bottomline CharitySymptoms of Anal CancerSex and CancerAnal Cancer BMJ Best Practice Breakthrough in anal cancer treatmentPLATO Act 3, 4 and 5Nigro ProtocolRad Chat Links:Rad Chat WebsiteLink TreeFacebookInstagramLinkedInTikTokBlueSkyYouTubeCredits: Music and jingle credits: Dr. Ben Potts and Adam Cooke.© Rad Chat 2025. All rights reserved.  We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  You must not use any images, audio, video, graphics or clips separately from their accompanying context.  Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.